Back
Emerson Electric 10K Form
Buy
67
EMR
Emerson Electric
Last Price:
95.61
Seasonality Move:
5.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2022-11-14 | 10K | EMR/Emerson Electric Annual |
2021-11-15 | 10K | EMR/Emerson Electric Annual |
2021-02-03 | 10Q | EMR/Emerson Electric Quarterly |
2020-11-16 | 10K | EMR/Emerson Electric Annual |
2020-08-05 | 10Q | EMR/Emerson Electric Quarterly |
2020-04-24 | 10Q | EMR/Emerson Electric Quarterly |
Receive EMR News And Ratings
See the #1 stock for the next 7 days that we like better than EMR
EMR Financial Statistics
Sales & Book Value
Annual Sales: | $19.63B |
---|---|
Cash Flow: | $721M |
Price / Cash Flow: | 28.24 |
Annual Sales: | $35.81 |
Price / Book: | 2.67 |
Profitability
EPS (TTM): | 22.87000 |
---|---|
Net Income (TTM): | $13.22B |
Gross Margin: | $8.19B |
Return on Equity: | 104.5% |
Return on Assets: | 34.91% |
Emerson Electric Earnings Forecast
Key Emerson Electric Financial Ratios
- The Gross Profit Margin over the past 39 years for EMR is 41.71%.
- The Selling, General & Administrative Expenses for EMR have been equal to 21.64% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 7.06% of Operating Income.
- The Net Earning history of EMR is 16.46% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 31 years.
Emerson Electric Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Specialty Industrial Machinery |
Sector: | Industrials |
Current Symbol: | EMR |
CUSIP: | 291011 |
Website: | emerson.com |
Debt
Debt-to-Equity Ratio: | 0.41 |
---|---|
Current Ratio: | 2.38 |
Quick Ratio: | 1.88 |
Price-to-Earnings
Trailing P/E Ratio: | 17.67 |
---|---|
Forward P/E Ratio: | 19.51 |
EMR Technical Analysis vs Fundamental Analysis
Buy
67
Emerson Electric (EMR)
is a Buy
Is Emerson Electric a Buy or a Sell?
-
Emerson Electric stock is rated a Buy
The current Emerson Electric [EMR] share price is $95.60. The Score for EMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.